Jagsonpal Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on November 11, 2016, to consider and approve the Un-audited Financial Results (provisional) of the Company for the second quarter/ and half year ended September 30, 2016.
The above information is a part of company’s filings submitted to BSE.